Dr. Michael Mousseau is a PhD in neuroscience, studying neurotransmitters in the brain such as oxytocin, serotonin and dopamine, which he now applies to workplace productivity and best practices for employee engagement with Gallagher Benefit Services, one of the largest consulting firms in North America. Dr. Mousseau talks to us about all things workplace productivity and in particular, how our brains are responding to the added stressors of the COVID-19 pandemic.  

👉 Connect for the latest insights directly in your feed: headversity on LinkedIn